Millipore Corporation has announced the opening of its expanded, state-of-the-art, single-use biomanufacturing facility in Danvers, Massachusetts. The 33,000-square-foot expansion concentrates on producing a wide range of Millipore’s Mobius® single-use technologies, including components of the newly introduced Mobius FlexReady Solutions. “We’re pleased to mark the completion of this facility because single-use technologies are becoming such an integral part of the biopharmaceutical landscape and our customers’ processes,” said Jean-Paul Mangeolle, President, Bioprocess Division, Millipore. “This expansion demonstrates our ability to stay at the forefront of the industry and our commitment to single-use technologies.” Millipore, a key player in the Massachusetts Biotech Corridor, has invested approximately $3.5 million dollars in the new Danvers bioprocess facility, which will employ approximately 120 people. The new facility contains 12,500 square feet of Class 10,000 clean room space and is in the process of becoming LEED® Gold certified. The newly added, state-of-the-art manufacturing space will focus on manufacturing components of Millipore’s Mobius single-use solutions, and allows for scale-up when additional manufacturing capacity is needed. “Our Mobius single-use technologies and especially our new Mobius FlexReady Solutions are unmatched by any competitive offering on the market today. Operational flexibility is key as companies turn more and more to single-use technologies. This facility allows us to meet this increasing demand and helps us meet our customers’ needs,” said Paul Chapman, Vice President, Downstream Processing, Millipore.